Hirotake Tsukamoto Selected Research

Hirotake Tsukamoto Research Topics

Disease

29	Neoplasms (Cancer) 03/2024 - 02/2004
5	Melanoma (Melanoma, Malignant) 01/2022 - 01/2018
3	Inflammation (Inflammations) 01/2021 - 07/2017
3	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2018 - 03/2017
2	Renal Cell Carcinoma (Grawitz Tumor) 07/2023 - 03/2016
2	Stomach Neoplasms (Stomach Cancer) 01/2023 - 07/2006
1	Lung Neoplasms (Lung Cancer) 12/2023
1	Pneumonia (Pneumonitis) 07/2023
1	Breast Neoplasms (Breast Cancer) 06/2023
1	COVID-19 02/2022
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2021
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021
1	Experimental Melanoma 01/2020
1	Colitis 01/2019
1	Bacterial Infections (Bacterial Infection) 07/2017
1	Virus Diseases (Viral Diseases) 07/2017
1	Infections 03/2017
1	Hepatocellular Carcinoma (Hepatoma) 01/2016
1	Testicular Neoplasms (Testicular Cancer) 01/2014
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2014
1	Autoimmune Diseases (Autoimmune Disease) 01/2014
1	Osteosarcoma (Osteogenic Sarcoma) 06/2013
1	Neoplasm Metastasis (Metastasis) 06/2013
1	Sarcoma (Soft Tissue Sarcoma) 06/2013
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2013
1	Wilms Tumor (Wilm's Tumor) 01/2013
1	Colonic Neoplasms (Colon Cancer) 07/2006
1	Pancreatic Neoplasms (Pancreatic Cancer) 07/2006
1	Esophageal Neoplasms (Esophageal Cancer) 10/2004

Drug/Important Bio-Agent (IBA)

11	AntigensIBA 03/2024 - 02/2004
11	CytokinesIBA 07/2023 - 02/2004
9	Peptides (Polypeptides)IBA 01/2022 - 01/2013
6	EpitopesIBA 02/2021 - 01/2013
5	Messenger RNA (mRNA)IBA 02/2022 - 10/2004
5	Interleukin-6 (Interleukin 6)IBA 01/2020 - 07/2013
4	Immune Checkpoint InhibitorsIBA 07/2023 - 01/2020
4	Complementary DNA (cDNA)IBA 06/2016 - 10/2004
3	Neoplasm Antigens (Tumor Antigens)IBA 01/2020 - 10/2004
3	Pattern Recognition ReceptorsIBA 01/2018 - 03/2017
3	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2014 - 01/2013
2	ChemokinesIBA 07/2023 - 01/2018
2	Indicators and Reagents (Reagents)IBA 01/2023 - 12/2021
2	VaccinesIBA 02/2022 - 01/2016
2	MicroRNAs (MicroRNA)IBA 02/2022 - 03/2017
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 06/2021 - 01/2020
2	NivolumabIBA 01/2019 - 01/2018
2	InterleukinsIBA 03/2018 - 07/2013
2	Viral RNAIBA 07/2017 - 03/2017
2	Pathogen-Associated Molecular Pattern MoleculesIBA 07/2017 - 03/2017
2	Interferon Type IIBA 07/2017 - 03/2017
2	HLA-DR Antigens (HLA-DR)IBA 03/2016 - 01/2013
2	Proteins (Proteins, Gene)FDA Link 07/2006 - 10/2004
1	LigandsIBA 12/2023
1	AutoantibodiesIBA 07/2023
1	platelet-derived growth factor C (PDGF-C)IBA 01/2023
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2023
1	Interleukin-12 (IL 12)IBA 01/2023
1	PhosphatidylserinesIBA 01/2023
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2023
1	BNT162 VaccineIBA 02/2022
1	Death Domain ReceptorsIBA 01/2022
1	GlucansIBA 12/2021
1	pullulanIBA 12/2021
1	Caspase 9IBA 06/2021
1	AP 1903 reagentIBA 06/2021
1	Ganciclovir (Cytovene)FDA LinkGeneric 06/2021
1	Thymidine KinaseIBA 06/2021
1	Papillomavirus Vaccines (HPV Vaccines)IBA 01/2021
1	OX40 LigandIBA 01/2020
1	OvalbuminIBA 01/2020
1	Therapeutic UsesIBA 10/2019
1	InterferonsIBA 10/2019
1	Immune Checkpoint ProteinsIBA 01/2018
1	B7-H1 AntigenIBA 01/2018
1	SmokeIBA 07/2017
1	Toll-Like Receptors (Toll-Like Receptor)IBA 03/2017
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2017
1	Transcription Factors (Transcription Factor)IBA 01/2017
1	Carrier Proteins (Binding Protein)IBA 06/2016
1	Insulin-Like Growth Factor II (Somatomedin A)IBA 06/2016
1	HLA Antigens (Human Leukocyte Antigens)IBA 03/2016
1	GlypicansIBA 01/2016
1	EnzymesIBA 01/2014
1	KinesinsIBA 08/2013
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 06/2013
1	Antineoplastic Agents (Antineoplastics)IBA 06/2013
1	corosolic acidIBA 06/2013
1	peptide AIBA 01/2013
1	HLA-DR4 Antigen (HLA DR4 Antigen)IBA 01/2013
1	Protein Subunit VaccinesIBA 01/2013
1	HLA-DRB1*04 antigenIBA 01/2013
1	HLA-DR alpha-ChainsIBA 01/2013
1	Small Interfering RNA (siRNA)IBA 07/2006
1	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2006
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 07/2006

Therapy/Procedure

15	Immunotherapy 06/2023 - 10/2004
11	Therapeutics 12/2023 - 07/2006
1	Cell- and Tissue-Based Therapy (Cell Therapy) 02/2021
1	Aftercare (After-Treatment) 02/2021
1	Injections 02/2021